Nichole Haeg: GLP-1s and Fertility
Nichole Haeg, Account Manager – Pharmacy Practice Specialist at American Health and Wellness, shared a post on LinkedIn:
“GLP-1s and Fertility – A secret key and a needed counseling point!
Here are my key take ways to consider:
- Currently, GLP-1s are not FDA approved for use in enhancing fertility, but research is ongoing.
- These medications show promise in improving fertility, especially in individuals with conditions like PCOS or obesity.
- The enhancement of fertility is attributed to factors such as weight reduction, improved insulin sensitivity, and the restoration of endocrine balance and endometrial receptivity.
- It is recommended to discontinue the use of GLP-1s four weeks before attempting conception and to avoid their use once pregnancy is confirmed.
- Ongoing research is crucial to gather more data on the effects of GLP-1s on fertility.
- For female patients not planning pregnancy, it’s important to educate them about the potential ‘side effect’ of increased fertility.
I am interested to see more research regarding this relationship between GLP-1s and fertility.
Tavares ACM, Martins MYM, de Souza GF, Lima EM, Rocha CA, de Souza LC, Simões JML, de Araújo NO, Cavalcante MB. Immunological effects of GLP-1 analogs on female reproduction: Therapeutic perspectives for infertility and recurrent pregnancy loss. J Reprod Immunol. 2025 Jun;169:104538. doi: 10.1016/j.jri.2025.104538. Epub 2025 May 8. PMID: 40359784.
Couldwell M, Tidwell AJ, Taylor AE. Impact of GLP1 agonists on reproduction. J Clin Endocrinol Metab. 2025 Jul 14:dgaf401. doi: 10.1210/clinem/dgaf401. Epub ahead of print. PMID: 40658801.
Sola-Leyva A, Pathare ADS, Apostolov A, Aleksejeva E, Kask K, Tammiste T, Ruiz-Durán S, Risal S, Acharya G, Salumets A. The hidden impact of GLP-1 receptor agonists on endometrial receptivity and implantation. Acta Obstet Gynecol Scand. 2025 Feb;104(2):258-266. doi: 10.1111/aogs.15010. Epub 2024 Dec 18. PMID: 39696822; PMCID: PMC11782050.”
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Nov 5, 2025, 13:34Nibhash Kumar: When Embryos Stop Growing and the Hidden Reasons Behind Early Developmental Arrest
-
Nov 5, 2025, 13:29Ahsan Saeed: DNA From Three Parents Just Stopped a Life-Threatening Disorder Before Birth!
-
Nov 5, 2025, 13:24New Weighted Classification Criteria Refine Antiphospholipid Syndrome Research – Hæmatologi DK
-
Nov 4, 2025, 15:34Optimal Endometrial Thickness Up to 12 mm Boosts Live Birth Rates in IVF – Fertility Plus
-
Nov 4, 2025, 15:20hCG and GnRH Analogue Trigger Show Similar Outcomes in IVF Cycles – Fertility Plus
-
Nov 4, 2025, 15:08Nyakaishiki Mercy: Pregnant Women Shouldn’t Get Leave From Work
-
Nov 4, 2025, 14:55Fewer Preeclampsia Cases Reported With Closed-Loop Insulin Use in Type 1 Diabetic Pregnancies – Medical Xpress
-
Nov 4, 2025, 14:42Meghna Rao: Exploring the Role of the Gut Microbiome in Women’s Reproductive Health
-
Nov 4, 2025, 14:23Fatemeh Zarimeidani: Advancing Care for PCOS-Related Infertility